Judy E. Garber, MD, MPH, on Triple-Negative Breast Cancer: An Update

2017 ESMO Congress
Tweet this page

Judy E. Garber, MD, MPH, of Dana-Farber Cancer Institute, offers expert perspectives on the role of PARP inhibitors in treating triple-negative breast cancer.

Advertisement

Advertisement



Advertisement